Alnylam Pharmaceuticals
ALNY
#555
Rank
$45.00 B
Marketcap
$339.37
Share price
2.01%
Change (1 day)
35.47%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company